Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$62.62 - $83.59 $1.33 Million - $1.77 Million
-21,215 Reduced 7.85%
249,029 $20.5 Million
Q1 2024

May 14, 2024

SELL
$54.0 - $71.06 $4.15 Million - $5.46 Million
-76,886 Reduced 22.15%
270,244 $17.9 Million
Q4 2023

Feb 13, 2024

BUY
$45.37 - $58.41 $8.61 Million - $11.1 Million
189,839 Added 120.69%
347,130 $19.7 Million
Q3 2023

Nov 13, 2023

BUY
$53.45 - $67.01 $131,112 - $164,375
2,453 Added 1.58%
157,291 $8.57 Million
Q2 2023

Aug 14, 2023

SELL
$50.38 - $68.21 $11.1 Million - $15.1 Million
-221,199 Reduced 58.82%
154,838 $10.4 Million
Q1 2023

May 12, 2023

SELL
$44.73 - $51.68 $3.92 Million - $4.53 Million
-87,595 Reduced 18.89%
376,037 $19.4 Million
Q4 2022

Feb 13, 2023

BUY
$41.94 - $52.25 $977,118 - $1.22 Million
23,298 Added 5.29%
463,632 $21.3 Million
Q3 2022

Nov 14, 2022

SELL
$45.29 - $55.99 $954,215 - $1.18 Million
-21,069 Reduced 4.57%
440,334 $22.3 Million
Q2 2022

Aug 12, 2022

BUY
$39.05 - $47.85 $18 Million - $22.1 Million
461,403 New
461,403 $21 Million

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.04B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Cramer Rosenthal Mcglynn LLC Portfolio

Follow Cramer Rosenthal Mcglynn LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cramer Rosenthal Mcglynn LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cramer Rosenthal Mcglynn LLC with notifications on news.